Atlas Trials

SURVEY-CNS: A Feasibility Study of Randomising Women and Men With HER2-Positive Metastatic Breast Cancer to Central Nervous System Surveillance Versus No Surveillance

Clinical trial NCT07503717 · RECRUITING

Trial details

NCT number
NCT07503717
Sponsor
Royal College of Surgeons, Ireland
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast CancerHER2-Positive Metastatic Breast Cancer
Start date
2025-06-01
Primary completion
2027-06-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.